131.59
price down icon0.21%   -0.28
after-market アフターアワーズ: 131.59
loading
前日終値:
$131.87
開ける:
$131.86
24時間の取引高:
6.08M
Relative Volume:
0.94
時価総額:
$229.03B
収益:
$43.11B
当期純損益:
$13.94B
株価収益率:
16.49
EPS:
7.98
ネットキャッシュフロー:
$6.78B
1週間 パフォーマンス:
+0.26%
1か月 パフォーマンス:
+3.99%
6か月 パフォーマンス:
-3.21%
1年 パフォーマンス:
+16.76%
1日の値動き範囲:
Value
$131.38
$132.35
1週間の範囲:
Value
$131.34
$133.81
52週間の値動き範囲:
Value
$110.86
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1150)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-07-17
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
131.59 226.73B 43.11B 13.94B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.39 152.69B 18.49B 2.50B 3.49B 1.68
Medical Devices icon
SYK
Stryker Corp
394.33 145.89B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
92.18 118.91B 33.54B 4.69B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
81.27 45.97B 5.69B 1.41B 577.90M 6.95

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Aug 20, 2025

Top Research Reports for Amazon.com, Salesforce & Abbott - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Abbott Sues Chinese Rival Over Glucose Monitor UK Patent - Law360

Aug 20, 2025
pulisher
Aug 20, 2025

Abbott Gets $7 Million Shaved From Tax Value of Minnesota Lab - news.bloombergtax.com

Aug 20, 2025
pulisher
Aug 20, 2025

Should You Invest in Abbott (ABT) Based on Bullish Wall Street Views? - Yahoo Finance

Aug 20, 2025
pulisher
Aug 19, 2025

Abbott gets 2nd formula lawsuit dismissed, spelling trouble for 700 cases - Crain's Chicago Business

Aug 19, 2025
pulisher
Aug 19, 2025

Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com

Aug 19, 2025
pulisher
Aug 19, 2025

Stock Analysis | Abbott Laboratories OutlookMixed Signals Amid Fundamental Strength - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Aug 19, 2025
pulisher
Aug 19, 2025

Alcohol assay from Carolina Liquid Chemistries receives CLIA moderate complexity categorization on Abbott ImmTox™ 270 chemistry analyzer - News-Medical

Aug 19, 2025
pulisher
Aug 19, 2025

1 Cash-Producing Stock for Long-Term Investors and 2 We Question - FinancialContent

Aug 19, 2025
pulisher
Aug 18, 2025

Synlait mum on rumoured US buyer for 'cash burning' Pōkeno plant - ThePost.co.nz

Aug 18, 2025
pulisher
Aug 18, 2025

Abbott Shares Slide 1.12% as Trading Volume Dives 43.81% to 182nd Rank Amid Blood Campaign Push - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

Abbott Laboratories scores a win in federal court, as it faces hundreds of suits over formula for preterm babies - Chicago Tribune

Aug 18, 2025
pulisher
Aug 18, 2025

Here's Why We Think Abbott Laboratories (NYSE:ABT) Is Well Worth Watching - 富途牛牛

Aug 18, 2025
pulisher
Aug 18, 2025

$1 Million Prize: Abbott and Big Ten's Massive Blood Drive Competition Returns After 12,000 Lives Saved - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Abbott Gains in Nutrition With Adult Segment Leading Growth - Yahoo Finance

Aug 18, 2025
pulisher
Aug 18, 2025

Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt - Yahoo Finance

Aug 18, 2025
pulisher
Aug 18, 2025

Synlait to sell plant to Abbott Labs as a2 Milk buys asset from rival - The Australian

Aug 18, 2025
pulisher
Aug 17, 2025

Abbott Laboratories Sheds 8% On A Rare Guidance Miss - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Aug 17, 2025
pulisher
Aug 16, 2025

What is the target price for Abbott Laboratories stockWeekly Risk Report & Growth Focused Investment Plans - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Insider Sales: D-Wave, AGNC, BigBearai, Abbott, Etsy - TipRanks

Aug 16, 2025
pulisher
Aug 16, 2025

2 Stocks to Buy on the Dip and Hold for 10 Years - The Motley Fool

Aug 16, 2025
pulisher
Aug 15, 2025

EXPERT EVIDENCE—BABY PRODUCTS—N.D. Ill.: Expert’s testimony did not apply to preterm infant; Abbott Labs thus entitled to summary judgment in baby formula litigation - VitalLaw.com

Aug 15, 2025
pulisher
Aug 15, 2025

Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

How Abbott Laboratories stock performs during market volatilityJuly 2025 Outlook & Reliable Price Breakout Signals - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

Abbott Shares Dip Despite Record Volume Surge and FDA Approval Targets 20 CAGR Market Ranks 57th in Daily Trading Activity - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Abbott Taps Growing TMVR Market With Tendyne System - The Globe and Mail

Aug 14, 2025
pulisher
Aug 14, 2025

Does Abbott Laboratories (NYSE:ABT) Deserve A Spot On Your Watchlist? - Yahoo Finance

Aug 14, 2025
pulisher
Aug 13, 2025

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT) - msn.com

Aug 13, 2025
pulisher
Aug 13, 2025

Saudi Arabia Blood Glucose Device Market Trends and Company - GlobeNewswire

Aug 13, 2025
pulisher
Aug 13, 2025

Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - Yahoo Finance

Aug 13, 2025
pulisher
Aug 12, 2025

Chris Blumas' Past Picks: Brookfield Corp, Abbott Labs & Great-West Lifeco - BNN Bloomberg

Aug 12, 2025
pulisher
Aug 12, 2025

United States Epilepsy Drugs Market Trends and Company - GlobeNewswire

Aug 12, 2025
pulisher
Aug 12, 2025

United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

Abbott India's profit climbs on healthy pharmaceutical demand - Reuters

Aug 12, 2025
pulisher
Aug 11, 2025

Top Abbott Executive Makes Significant Stock Sale! - TipRanks

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Plummets 2.17% Amid Regulatory Scrutiny as Volume Surges 40.74% to 940M Ranking 93rd - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Shakes Suit Over Meta, Google Data Sharing For Now - Law360

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories EVP and CFO Sells 5,550 Shares at $134.55/Share on August 8, 2023. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories poised to end in red after six-session rally - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories Faces Correction Amid Six-Session Rally - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Labs Beats Class Action Over Meta, Google Info Sharing - Bloomberg Government News

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories shows growth in core products amid market shifts - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink? - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Abbott Laboratories maintains steady performance amid market shifts - Express Healthcare

Aug 11, 2025
pulisher
Aug 10, 2025

Abbott Laboratories (NYSE:ABT) jumps 5.5% this week, though earnings growth is still tracking behind five-year shareholder returns - Yahoo Finance

Aug 10, 2025
pulisher
Aug 09, 2025

Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Abbott Laboratories Q2 Earnings: Dividends Don’t Lie (NYSE:ABT) - Seeking Alpha

Aug 09, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$106.39
price up icon 1.22%
medical_devices SYK
$394.33
price up icon 0.88%
medical_devices MDT
$92.18
price up icon 0.17%
medical_devices EW
$81.27
price up icon 0.48%
$74.09
price down icon 0.67%
大文字化:     |  ボリューム (24 時間):